Collectif P1.5, 80, allée des Ormes, 06250 Mougins, France; Centre ophtalmologique, Hôpital Privé Arnault Tzanck Mougins Sophia-Antipolis, 80, allée des Ormes, 06250 Mougins, France.
Collectif P1.5, 80, allée des Ormes, 06250 Mougins, France; AixVision, 44, avenue Maréchal-de-Lattre-de-Tassigny, 13090 Aix-en-Provence, France.
J Fr Ophtalmol. 2021 Sep;44(7):1038-1046. doi: 10.1016/j.jfo.2021.05.002. Epub 2021 Jun 17.
Lacking a standard technique, the surgical management of aphakia without capsular support remains to be optimized. The goal of this study is to analyze results for the Carlevale FIL-SSF intraocular lens and propose surgical recommendations.
The P1.5 Collective performed a retrospective analysis, with a minimum follow-up of 6 months, of the records of 72 implantations of the Carlevale FIL-SSF intraocular lens, specifically designed for sutureless scleral fixation in the ciliary sulcus.
The most common indication was exchange of a posterior chamber intraocular lens (70.8%). The surgery lasted a mean of 53.4minutes due to the creation of scleral flaps. The implant was damaged in 12.5% of cases. Visual acuity was improved in 83.3% of cases. The postoperative spherical equivalent was -0.3 diopters, with no change in corneal astigmatism. The implant was centered and stable in all cases. Two cases (2.8%) of cystoid macular edema were observed and resolved over six months.
A number of advantages of the Carlevale FIL-SSF intraocular lens make it a safe and effective solution for correction of aphakia in the absence of capsular support. It requires a longer than usual surgical procedure, and the implant must be handled with care. From their experience, the authors propose 7 recommendations to accelerate the learning curve.
In light of the results of this study, we propose the Carlevale FIL-SSF intraocular lens as the new standard for the correction of aphakia without capsular support, but other studies are necessary to determine its exact place within the heirarchy of other available techniques.
由于缺乏标准技术，因此仍需要优化无囊袋支持的白内障术后处理。本研究旨在分析 Carlevale FIL-SSF 人工晶状体的结果，并提出手术建议。
P1.5 集团进行了回顾性分析，对 72 例 Carlevale FIL-SSF 人工晶状体植入术患者的记录进行了分析，这些患者均接受了无缝线巩膜固定于睫状沟的治疗。
最常见的适应证是更换后房人工晶状体（70.8%）。由于制作了巩膜瓣，手术平均持续 53.4 分钟。在 12.5%的情况下，植入物受损。83.3%的患者视力得到改善。术后等效球镜为-0.3 屈光度，角膜散光无变化。所有病例均植入物居中且稳定。观察到 2 例（2.8%）患者发生囊样黄斑水肿，6 个月后消退。
Carlevale FIL-SSF 人工晶状体具有许多优点，使其成为无囊袋支持的白内障矫正的安全有效解决方案。该手术需要比常规手术更长的时间，并且必须小心处理植入物。根据他们的经验，作者提出了 7 条建议来加速学习曲线。
根据这项研究的结果，我们建议将 Carlevale FIL-SSF 人工晶状体作为无囊袋支持的白内障矫正的新标准，但需要进行其他研究来确定其在其他可用技术中的确切位置。
